Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer. - Wikidata - awgldk - TriplyDB

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

http://www.wikidata.org/entity/Q34216236

about

Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?Targeting the adaptive molecular landscape of castration-resistant prostate cancer A survey of best practices for RNA-seq data analysis Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens.Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status Mutational Landscape of Aggressive Prostate Tumors in African American Men Transcriptional profiling analysis and functional prediction of long noncoding RNAs in cancer.Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.Novel transcription-induced fusion RNAs in prostate cancer.Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.The potential of organoids in urological cancer research Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin.Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.Cancer genomics just got personal.PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneity.Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression.Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.Analyzing large scale genomic data on the cloud with Sparkhit.TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

P2860

Q26781271-C32D707E-ACF1-4CB3-8A62-19E86B1E5F3D Q27022821-BA87CDF9-F867-454C-852F-E38BC36FCAF0 Q28071394-7F8B5A21-807A-46A3-B1B0-FCEAAE503BC0 Q35331865-BE18E281-2615-4DB6-904F-486CBCC95C54 Q35968893-E297CE7F-B8AC-4D75-9D5D-FED4C3FF5BB9 Q36381818-E877FF00-6DDC-4098-873B-A3B5586AEDD8 Q36633535-7A0E56C6-04F7-4254-A4A5-EF694AAA7901 Q36946733-B6D4F42D-6DF6-4D75-96D0-C7338F629550 Q37251140-7F3CB745-CDFB-4603-9E8A-9E336331097D Q37564369-CF7C6B9D-6D15-4C89-BC69-1421BB96B227 Q38806903-5261383D-C346-4E10-A1E9-99563F3985B9 Q38810786-7430B83F-5E66-44B1-B50A-1FAA3697243F Q39324348-D0894786-C306-4407-AD92-BE7418C28CDA Q40053323-DFDFC232-88C8-447D-9922-C464BB3EBEF3 Q40656134-04359029-D3B7-4741-9DDE-F8EBB322BF99 Q42027887-452FE00A-469E-4CD6-94A3-E873A5E93B62 Q42114642-BC218EFF-D35F-4B26-A6CE-570BA06976BF Q42139770-3903FBD9-D8F5-41D5-95A5-388C823447C0 Q42335698-BA2F1ED9-D134-4073-9767-5D1F2D120229 Q46007270-F2D17317-1BED-4C1B-B375-62998844A7E1 Q47097550-75F39D92-BDFF-4C7A-BA70-21102D203A3B Q47111629-E968F211-5B7C-463C-9394-CD029351B17F Q47290661-DD4EFD52-BFE5-4F05-9B9D-C5693E04B4D5 Q49959247-975E82D0-9F63-4585-A4EE-EB9C9F5D96DC Q52645860-3C9941D5-A75D-4F58-B9B1-59FA142F77C1 Q53682879-9C3CCD60-D501-43DB-9A02-770799C6A74D

P2860

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

http://www.wikidata.org/entity/Q34216236

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@ast

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@en

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@nl

type

label

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@ast

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@en

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@nl

prefLabel

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@ast

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@en

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@nl

P1433

Q34216236-88FAD64B-3749-4624-9BD9-A4CDB64AE32A

P1476

Q34216236-8DD4292B-65C6-4CC3-9A71-D05B954A00EF

P2093

Q34216236-04AECBAC-5D55-456B-BC58-9A9F4220B5A3

Q34216236-137920AF-EA51-4DCD-AF9E-94EC84B6668E

Q34216236-19EFD046-C584-4A40-B962-26E055509874

Q34216236-1F99133A-5ECB-4D08-8AA6-244A6CEB8E8F

Q34216236-24432012-D603-42B8-900D-306457EC3C77

Q34216236-2E3F8C13-9406-44CB-BF5A-EDE62ED0F202

Q34216236-350D3C8E-CDF3-4D3F-B3F0-E4606E1870E8

Q34216236-3600AAEF-7594-48BF-A796-3CF280D0CD19

Q34216236-3E90E55C-E3AD-420B-95D2-E2AE6AA4B5F5

Q34216236-430D9237-1D85-43C1-87A0-E73BB336C625

P2860

Q34216236-014DAAA2-69C7-4F80-9922-19DA18F900BC

Q34216236-01EA06CB-E363-42D4-9561-A41D472FD937

Q34216236-03127D0F-AF24-441E-AA53-2DB5726B28F3

Q34216236-0318FDFE-DB03-4D92-A120-C0916C401349

Q34216236-037AB394-F071-4899-903E-1D7A42B86802

Q34216236-03B6F00E-CBEA-43C6-A58B-C77F0B801C3F

Q34216236-0B387739-76E8-4D11-AC65-424E7BDDCD6A

Q34216236-1FFE7A61-2BB3-4E97-8334-7AEE11623A79

Q34216236-27D51790-DB6B-478B-BF90-82C8CCA09ED8

Q34216236-29F22881-E1C7-4414-AABD-A4415060CA8A

P2888

Q34216236-1317314E-7E58-4C24-9BFC-8495CBDE386E

P304

Q34216236-343062CC-24BF-459E-AF97-E784092B4E09

P31

Q34216236-3DD36907-CE23-4EB4-BB8D-AFB325433E1B

P356

Q34216236-299ABF04-E1BB-463F-BE3A-4C5331CB1EC8

P433

Q34216236-61B10305-6B84-4CB2-A851-A6B3760EEBA8

P478

Q34216236-081DEA78-2BC1-47C8-9C11-95FF185D5FA9

P577

Q34216236-E246A18E-607F-43D6-AF89-55541ACE66D2

P698

Q34216236-EEF102E8-E483-4F46-BE35-96B19C8A7D76

P921

Q34216236-5D202B64-26B1-4F61-B8AE-C4E4541F9ADD

P932

Q34216236-F99D8D8D-9D29-4BCF-8148-260394D50F43

P356

PREACCEPT-1882913817126479

P1433

P1476

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

@en

P2093

Alexander W Wyatt

http://www.w3.org/2001/XMLSchema#string

Andrew McPherson

http://www.w3.org/2001/XMLSchema#string

Anna V Lapuk

http://www.w3.org/2001/XMLSchema#string

Anne Haegert

http://www.w3.org/2001/XMLSchema#string

Antonio Hurtado-Coll

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Brian McConeghy

http://www.w3.org/2001/XMLSchema#string

Colin C Collins

http://www.w3.org/2001/XMLSchema#string

Devon M Mitchell

http://www.w3.org/2001/XMLSchema#string

Dong Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression analysis for sequence count data

Cancer genome landscapes

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

Complex landscapes of somatic rearrangement in human breast cancer genomes.

The role of SPINK1 in ETS rearrangement-negative prostate cancers

A census of human cancer genes

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

TopHat: discovering splice junctions with RNA-Seq

eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition

P2888

preaccept-1882913817126479

P304

426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/PREACCEPT-1882913817126479

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25155515

http://www.w3.org/2001/XMLSchema#string

P921

P932

4169643

http://www.w3.org/2001/XMLSchema#string